logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Early TNBC: adding ipatasertib to neoadjuvant paclitaxel shows benefit in phase 2

Best results were seen in biomarker-selected patients on breast MRI.